Piramal Pharma Limited — Iron Exporter Profile
Indian Pharmaceutical Exporter · #15 for Iron · $3.8M export value · DGFT Verified
Piramal Pharma Limited is the #15 Indian exporter of Iron with $3.8M in export value and 105 verified shipments. Piramal Pharma Limited holds a 0.8% market share in Iron exports across 3 countries. The company exports 8 pharmaceutical products worth $64.5M across 5 therapeutic categories.
Piramal Pharma Limited — Iron Export Profile: Buyers & Destinations
Where Does Piramal Pharma Limited Export Iron?
| Country | Value | Shipments | Share |
|---|---|---|---|
| NETHERLANDS | $1.2M | 30 | 42.9% |
| UNITED KINGDOM | $1.0M | 27 | 38.2% |
| GERMANY | $516.1K | 48 | 18.8% |
Piramal Pharma Limited exports Iron to 3 countries. The largest destination is NETHERLANDS accounting for 42.9% of Piramal Pharma Limited's Iron shipments, followed by UNITED KINGDOM (38.2%) and GERMANY (18.8%). These destinations reflect Piramal Pharma Limited's established distribution network and regulatory approvals in key markets.
Who Are the Top Buyers of Iron from Piramal Pharma Limited?
| Buyer | Country | Value | Orders |
|---|---|---|---|
| LEXON UK LIMITED | UNITED KINGDOM | $997.5K | 26 |
| VTS TRANSPORT & LOGISTICS BV | NETHERLANDS | $614.6K | 16 |
| MERCKLE GMBH | GERMANY | $516.1K | 48 |
| BROCACEF HEALTHCARE LOGISTICS | NETHERLANDS | $310.9K | 9 |
| VTS TRANSPORT LOGISTICS BV | NETHERLANDS | $250.0K | 5 |
| LEXON UK LTD | UNITED KINGDOM | $50.0K | 1 |
Piramal Pharma Limited supplies Iron to 6 buyers globally. The largest buyer is LEXON UK LIMITED (UNITED KINGDOM), followed by VTS TRANSPORT & LOGISTICS BV (NETHERLANDS) and MERCKLE GMBH (GERMANY). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.
What Is India's Total Iron Export Value and How Much Does Piramal Pharma Limited Contribute?
India exported $148.4M worth of Iron through 14,943 shipments from 943 suppliers to 174 countries, serving 2,171 buyers globally. Piramal Pharma Limited contributes $3.8M to this total, accounting for 0.8% of India's Iron exports. Piramal Pharma Limited ships Iron to 3 countries through 6 buyers.
What Is the Average Shipment Value for Piramal Pharma Limited's Iron Exports?
Piramal Pharma Limited's average Iron shipment value is $35.7K per consignment, based on 105 shipments totaling $3.8M. The largest destination is NETHERLANDS (42.9% of Piramal Pharma Limited's Iron exports).
How Does Piramal Pharma Limited Compare to Other Indian Iron Exporters?
Piramal Pharma Limited ranks #15 among 943 Indian Iron exporters with a 0.8% market share. The top 3 exporters are UNICHEM LABORATORIES LIMITED ($32.2M), ZYDUS LIFESCIENCES LIMITED ($21.6M), AMNEAL PHARMACEUTICALS PRIVATE LIMITED ($18.8M). Piramal Pharma Limited processed 105 shipments to 3 destination countries.
What Iron Formulations Does Piramal Pharma Limited Export?
| Product Description / Formulation | Value | Shipments |
|---|---|---|
| Spironolactone 12.5mg Tab PVC BL 2x14sNL | $250.0K | 5 |
| SPIRONOLACTON 12.5MG TAB PVC BL2X14S NL(400691058) (141,020.000 SB)NOS | $104.4K | 3 |
| SPIRONOLACTONE 12.5 MG TB PVC BL 2 X 14S | $100.0K | 2 |
| Spironolactone 100mg Tabs PVC BL 2x14s ( | $100.0K | 2 |
| Spironolactone 50mg Tabs PVC BL 2x14s (4 | $100.0K | 2 |
| SPIRONOLACTON 12.5MG TAB BL 2X14s 20L NL(430960002) (69,300.000 SB) | $100.0K | 2 |
| (430807027) Buspirone HCl Tabs10mg 10x10 | $93.8K | 6 |
| SPIRONOLACTONE 12.5MG TAB VC BL2X14S UK(400691057) (95,466.000 SB ) | $64.0K | 3 |
| (430807024) Buspirone HCL Tabs10mg 250s | $61.2K | 3 |
| SPIRONOLACTONE 12.5MG TAB PVC BL2X14S UK(400691057) (71,629.000 SB ) | $53.0K | 3 |
Piramal Pharma Limited exports 71 distinct Iron formulations including tablets, capsules, syrups, and combination drugs. The top formulation is Spironolactone 12.5mg Tab PVC BL 2x14sNL with 5 shipments worth $250.0K.
Regulatory Requirements: Exporting Iron to Key Markets
What Piramal Pharma Limited must comply with to export Iron to its top destination countries
United Kingdom — MHRA
Approval Process
Post-Brexit UK Marketing Authorisation via national procedure. Separate from EU approval since January 2021.
Timeline: 12–15 months
GMP & Export Requirements
UK GMP compliance; MHRA inspection of manufacturing site
Manufacturer Import Authorisation (MIA) held by UK importer; Qualified Person (QP) batch release
Note: Post-Brexit: EU GMP certificates no longer automatically valid in UK. Separate MHRA recognition required.
Germany — BfArM/EMA
Approval Process
Marketing Authorisation via Decentralized or Mutual Recognition Procedure under EU Directive 2001/83/EC. CTD Module 1–5 dossier required.
Timeline: 12–18 months via Decentralized Procedure
GMP & Export Requirements
EU GMP (EudraLex Vol. 4); GMP certificate from EU competent authority; WHO Prequalification accepted as supporting evidence
Certificate of Pharmaceutical Product (CPP) from CDSCO; Written Confirmation for API export per EU requirements; EU FMD serialization mandatory
Note: Indian manufacturers must hold EU GMP certificate. EU Falsified Medicines Directive (FMD) serialization and tamper-evident packaging mandatory.
Regulatory information is provided for general reference based on publicly available guidelines. Requirements vary by formulation, dosage form, and therapeutic classification. Exporters should consult qualified regulatory affairs professionals for case-specific guidance.
How Does Piramal Pharma Limited Compare to Nearest Iron Exporters?
Exporters ranked immediately above and below #15 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 6 | MYLAN LABORATORIES LIMITED | $5.2M | 103 | 6 | $50.0K |
| 12 | AUROBINDO PHARMA LIMITED | $5.0M | 101 | 1 | $50.0K |
| 15 | PIRAMAL PHARMA LIMITED ★ | $3.8M | 105 | 3 | $35.7K |
| 14 | STRIDES ALATHUR PRIVATE LIMITED | $3.5M | 71 | 1 | $50.0K |
| 13 | CADILA HEALTHCARE LIMITED | $2.9M | 57 | 1 | $50.0K |
Piramal Pharma Limited ranks #15 among 943 Indian Iron exporters. Average shipment value of $35.7K compared to the market average of $157.4K. The closest competitors by value are MYLAN LABORATORIES LIMITED and AUROBINDO PHARMA LIMITED.
Which Indian Ports Ship Iron Exports?
| Port | Shipments | % Share |
|---|---|---|
| SAHAR AIR | 1,808 | 12.1% |
| SAHAR AIR CARGO ACC (INBOM4) | 1,771 | 11.9% |
| NHAVA SHEVA SEA (INNSA1) | 1,262 | 8.4% |
| DELHI AIR CARGO ACC (INDEL4) | 1,230 | 8.2% |
| DELHI AIR | 1,025 | 6.9% |
| JNPT/ NHAVA SHEVA SEA | 707 | 4.7% |
| MUNDRA SEA | 632 | 4.2% |
| JNPT | 627 | 4.2% |
What Other Vitamins & Supplements Products Does Piramal Pharma Limited Export?
Piramal Pharma Limited also exports these vitamins & supplements products. Each links to the detailed product page.
Geopolitical & Trade Policy Impact on Piramal Pharma Limited's Iron Exports
The current geopolitical landscape presents both challenges and opportunities for Indian pharmaceutical exporters like PPL. The Israel-Iran tensions have led to increased security risks in the Red Sea, prompting major shipping lines to impose 'Emergency Risk Surcharges' ranging from $250 to $500 per TEU. This escalation in shipping costs directly impacts the profitability of exports to Europe and the U.S. East Coast, necessitating strategic adjustments in logistics and pricing strategies. (sgexports.odoo.com)
Simultaneously, the 2025 United States–India diplomatic and trade crisis has introduced additional complexities. The U.S. administration's imposition of a 50% tariff on Indian exports, in response to India's energy policies, has significantly affected trade dynamics. This development compels companies like PPL to reassess their market strategies and explore alternative markets to mitigate the impact of these tariffs. (en.wikipedia.org)
On a positive note, the European Union's implementation of the Carbon Border Adjustment Mechanism (CBAM) has prompted the Directorate General of Foreign Trade (DGFT) in India to establish a 'CBAM Facilitation Cell.' This initiative aims to assist exporters in complying with new environmental regulations, potentially providing PPL with a competitive edge in the EU market by aligning with sustainability standards. (sgexports.odoo.com)
Piramal Pharma Limited — Regulatory Compliance & Quality Standards
Maintaining stringent quality standards is paramount for pharmaceutical exporters. PPL's Turbhe facility in Maharashtra underwent a U.S. FDA inspection in February 2025, resulting in a Form 483 with six observations. The company addressed these concerns, leading to the issuance of an Establishment Inspection Report (EIR) with a classification of Voluntary Action Indicated (VAI) in May 2025, signifying successful closure of the inspection. (business-standard.com)
Similarly, the Riverview facility in the U.S. received an EIR in April 2024, following a pre-approval inspection that concluded with three observations classified under VAI. These developments reflect PPL's proactive approach to regulatory compliance and its commitment to upholding global quality standards. (business-standard.com)
About Piramal Pharma Limited
Piramal Pharma Limited exports 8 products worth $64.5M. Beyond Iron, top products include Atorvastatin, Calcium, Ezetimibe, Carvedilol, Spironolactone. View the complete Piramal Pharma Limited profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Iron — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Iron shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
- 2.Supplier Identification: Piramal Pharma Limited matched across shipments using name normalization, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
- 4.Verified Records: This page is backed by 105 individual customs records matching Piramal Pharma Limited exporting Iron, covering 71 formulations to 3 countries via 6 buyers.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 174+ countries, 2,171+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Iron Export Data from Piramal Pharma Limited
Access shipment-level details, pricing data, buyer connections, and competitive analysis for Piramal Pharma Limited's Iron exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
Piramal Pharma Limited
Full Company Profile →
8 products · $64.5M total trade · 5 categories
Iron Stats
Company Overview
Top Products by Piramal Pharma Limited
Related Analysis
Need Detailed Export Data?
Access shipment-level records, pricing trends, and buyer contacts for Piramal Pharma Limited.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Iron. For current shipment-level data, contact TransData Nexus.